Originally published by our sister publication Pharmacy Practice News
When pharmacy leaders at The Johns Hopkins Hospital, in Baltimore, decided to produce their own IV syringe products, they went big—installing an 8-foot–high, 1,900-pound high-speed compounding robot.
Hospitals typically purchase IV syringes from 503B compounding facilities to get extended beyond-use dating (BUD) and medications in a ready-to-administer dosage form, said Matthew Broadwater, PharmD, MBA,